Gi Mo Jung

Pharmacokinetics and Tolerance of the Phage Endolysin-Based Candidate Drug SAL200 after a Single Intravenous Administration among Healthy Volunteers

Soo Youn Jun, In Jin Jang, Seonghae Yoon et al. · Antimicrobial Agents and Chemotherapy · 2017 · 173 citations · Full text

Pharmacotherapy, Physiologically-based Pharmacokinetic Modeling, Drug Resistance +18

Preclinical Safety Evaluation of Intravenously Administered SAL200 Containing the Recombinant Phage Endolysin SAL-1 as a Pharmaceutical Ingredient

Soo Youn Jun, Gi Mo Jung, Seong Jun Yoon et al. · Antimicrobial Agents and Chemotherapy · 2014 · 100 citations · Full text

Antibacterial properties of a pre-formulated recombinant phage endolysin, SAL-1

Soo Youn Jun, Gi Mo Jung, Seong Jun Yoon et al. · International Journal of Antimicrobial Agents · 2012 · 93 citations

Antibacterial Properties, Antibacterial Agent, Microbiology +4

Characterisation of the antibacterial properties of the recombinant phage endolysins AP50-31 and LysB4 as potent bactericidal agents against Bacillus anthracis

Sang-Jin Park, Soo Youn Jun, Changhwan Kim et al. · Scientific Reports · 2018 · 61 citations · Full text

Comparison of the Antibacterial Properties of Phage Endolysins SAL-1 and LysK

Soo Youn Jun, Gi Mo Jung, Jee Soo Son et al. · Antimicrobial Agents and Chemotherapy · 2011 · 59 citations · Full text

Bacteriophage, Drug Resistance, Phage Endolysin Sal-1 +16